Mobia Medical (NASDAQ:MOBI) Issues Earnings Results

Mobia Medical (NASDAQ:MOBI) posted its quarterly earnings results on Thursday. The company reported $999.00 EPS for the quarter, reports. The firm had revenue of $12.07 million for the quarter.

Mobia Medical Trading Down 8.8%

MOBI opened at $12.62 on Friday. The stock has a market cap of $417.53 million, a price-to-earnings ratio of 66.00 and a beta of 2.84. Mobia Medical has a 52-week low of $10.19 and a 52-week high of $14.77.

Insider Buying and Selling at Mobia Medical

In other Mobia Medical news, Director Casey M. Tansey acquired 66,666 shares of the stock in a transaction dated Monday, May 11th. The shares were purchased at an average price of $15.00 per share, for a total transaction of $999,990.00. Following the purchase, the director directly owned 233,332 shares of the company’s stock, valued at approximately $3,499,980. This trade represents a 40.00% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, Director William T. Harrington acquired 533,333 shares of the stock in a transaction dated Monday, May 11th. The stock was acquired at an average price of $15.00 per share, for a total transaction of $7,999,995.00. Following the purchase, the director directly owned 2,006,716 shares in the company, valued at approximately $30,100,740. This trade represents a 36.20% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders have purchased 1,268,332 shares of company stock worth $19,024,980.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on MOBI shares. Zacks Research raised shares of Mobia Medical to a “hold” rating in a research report on Wednesday. Wolfe Research started coverage on shares of Mobia Medical in a research report on Tuesday. They set an “outperform” rating on the stock. JPMorgan Chase & Co. began coverage on shares of Mobia Medical in a research report on Tuesday. They set an “overweight” rating and a $15.00 price objective on the stock. BTIG Research began coverage on shares of Mobia Medical in a research report on Tuesday. They issued a “buy” rating and a $19.00 target price on the stock. Finally, Wall Street Zen downgraded shares of Mobia Medical from a “hold” rating to a “sell” rating in a research report on Saturday. Five equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $20.25.